Ligand · 5LO
5LO · 4-[(11S,15R)-4,4,7,7-Tetramethyl-16-oxatetracyclo[8.6.0.03,8.011,15]hexadeca-1(10),2,8-trien-11-yl]benzoic acid
5LO, 4-[(11S,15R)-4,4,7,7-Tetramethyl-16-oxatetracyclo[8.6.0.03,8.011,15]hexadeca-1(10),2,8-trien-11-yl]benzoic acid (C26 H30 O3, 390.5 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site…
- Component
- 5LO
- Formula
- C26 H30 O3
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
5LO in 2 structures; the first of them:
- 5EC9 · Retinoic acid receptor alpha in complex with chiral dihydrobenzofuran benzoic acid 9a and… · 5LO A501 · binds VAL265, ILE268, ALA271, ALA272, GLN275, TRP305, ASN306, LEU309 and 15 more
- 5EC9 · Retinoic acid receptor alpha in complex with chiral dihydrobenzofuran benzoic acid 9A and… · 5LO A501 · binds VAL265, ILE268, ALA271, ALA272, GLN275, TRP305, ASN306, LEU309 and 15 more
Residues it binds most
ILE 2, LEU 2, ALA 2, PHE 2, VAL 2, ARG 2, ASN 2, CYS 2, GLN 2, HIS 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.